Loading...
Loading...
CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.
Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.